Medarex, LLC
Patent Applications and Registrations
Patent applications and USPTO patent grants for Medarex, LLC.The latest application filed is for "ctla-4 antibody dosage escalation regimens".
Company Profile
0.28.26
- Medarex, LLC - Princeton NJ US
- Medarex, L.L.C. - Princeton NJ US
Patent Activity
| Patent | Date |
|---|---|
| Methods for preparing interferon alpha antibodies Grant 9,765,141 - Witte , et al. September 19, 2 | 2017-09-19 |
| CTLA-4 antibody dosage escalation regimens Grant 9,573,999 - Nichol , et al. February 21, 2 | 2017-02-21 |
| Therapeutic human anti-IL-1R1 monoclonal antibody Grant 9,534,053 - Varnum , et al. January 3, 2 | 2017-01-03 |
| Fully human antibodies to BTLA Grant 9,346,882 - Mataraza , et al. May 24, 2 | 2016-05-24 |
| Antibodies against clostridium difficile toxins and uses thereof Grant 9,217,029 - Ambrosino , et al. December 22, 2 | 2015-12-22 |
| Ctla-4 Antibody Dosage Escalation Regimens App 20150246972 - Nichol; Geoffrey M. ; et al. | 2015-09-03 |
| Methods for treating cancer using anti-PD-1 antibodies Grant 9,084,776 - Korman , et al. July 21, 2 | 2015-07-21 |
| CTLA-4 antibody dosage escalation regimens Grant 9,062,111 - Nichol , et al. June 23, 2 | 2015-06-23 |
| Methods For Treating Cancer Using Anti-pd-1 Antibodies App 20150165025 - KORMAN; Alan J. ; et al. | 2015-06-18 |
| Ip-10 Antibodies And Their Uses App 20150104866 - DESHPANDE; Shrikant ; et al. | 2015-04-16 |
| Human anti-B7RP1 neutralizing antibodies Grant 8,981,071 - Siu , et al. March 17, 2 | 2015-03-17 |
| IP-10 antibodies and their uses Grant 8,945,546 - Deshpande , et al. February 3, 2 | 2015-02-03 |
| Transgenic Transchromosomal Rodents For Making Human Antibodies App 20140380515 - TOMIZUKA; KAZUMA ; et al. | 2014-12-25 |
| Monoclonal Antibodies To Programmed Death 1 (pd-1) App 20140348743 - Korman; Alan J. ; et al. | 2014-11-27 |
| Therapeutic Human Anti-il-1r1 Monoclonal Antibody App 20140335099 - Varnum; Brian ; et al. | 2014-11-13 |
| Methods For Treating Cancer Using Anti-pd-1 Antibodies App 20140328833 - Korman; Alan J. ; et al. | 2014-11-06 |
| Antiproliferative Compounds, Conjugates Thereof, Methods Therefor, And Uses Thereof App 20140323690 - Cheng; Heng ; et al. | 2014-10-30 |
| Site-specific attachment of drugs or other agents to engineered antibodies with C-terminal extensions Grant 8,865,875 - Liu , et al. October 21, 2 | 2014-10-21 |
| Methods For Enhanced Protein Production App 20140302581 - Arunakumari; Alahari ; et al. | 2014-10-09 |
| Monoclonal Antibodies To Programmed Death 1 (pd-1) App 20140294852 - Korman; Alan J. ; et al. | 2014-10-02 |
| Transgenic trasnchromosomal rodents for making human antibodies Grant 8,835,712 - Tomizuka , et al. September 16, 2 | 2014-09-16 |
| Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist Grant 8,828,393 - Pickford , et al. September 9, 2 | 2014-09-09 |
| Human Ctla-4 Antibodies And Their Uses App 20140234331 - Korman; Alan J. ; et al. | 2014-08-21 |
| Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof Grant 8,802,632 - Cheng , et al. August 12, 2 | 2014-08-12 |
| Methods For Treating Cancer Using Anti-pd-1 Antibodies In Combination With Anti-ctla-4 Antibodies App 20140212422 - Korman; Alan J. ; et al. | 2014-07-31 |
| Human CTLA-4 antibodies and their uses Grant 8,784,815 - Korman , et al. July 22, 2 | 2014-07-22 |
| Interferon Alpha Antibodies And Their Uses App 20140199328 - Witte; Alison ; et al. | 2014-07-17 |
| Monoclonal antibodies to programmed death 1 (PD-1) Grant 8,779,105 - Korman , et al. July 15, 2 | 2014-07-15 |
| Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof Grant 8,772,542 - Cheng , et al. July 8, 2 | 2014-07-08 |
| Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof Grant 8,772,543 - Cheng , et al. July 8, 2 | 2014-07-08 |
| Monoclonal Antibodies Against Glypican-3 App 20140186892 - Terrett; Jonathan Alexander ; et al. | 2014-07-03 |
| Methods for enhanced protein production Grant 8,765,415 - Arunakumari , et al. July 1, 2 | 2014-07-01 |
| Protein Purification Using Hcic And Ion Exchange Chromatography App 20140179904 - Arunakumari; Alahari ; et al. | 2014-06-26 |
| Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) Grant 8,758,757 - Cardarelli , et al. June 24, 2 | 2014-06-24 |
| Human Monoclonal Antibodies To O8e App 20140134180 - KORMAN; ALAN J. ; et al. | 2014-05-15 |
| Nucleic acids encoding interferon alpha antibodies Grant 8,722,870 - Witte , et al. May 13, 2 | 2014-05-13 |
| Antibodies Against Clostridium Difficile Toxins And Uses Thereof App 20140120614 - AMBROSINO; Donna M. ; et al. | 2014-05-01 |
| Therapeutic human anti-IL-1R1 monoclonal antibody Grant 8,710,203 - Varnum , et al. April 29, 2 | 2014-04-29 |
| Protein purification using HCIC and ion exchange chromatography Grant 8,697,847 - Arunakumari , et al. April 15, 2 | 2014-04-15 |
| Monoclonal antibodies against glypican-3 Grant 8,680,247 - Terrett , et al. March 25, 2 | 2014-03-25 |
| Chemical linkers with single amino acids and conjugates thereof Grant 8,664,407 - Chen , et al. March 4, 2 | 2014-03-04 |
| Fully Human Antibodies To Btla App 20140017255 - MATARAZA; Jennifer Marie ; et al. | 2014-01-16 |
| Antibodies against clostridium difficile toxins and uses thereof Grant 8,609,111 - Ambrosino , et al. December 17, 2 | 2013-12-17 |
| Human monoclonal antibodies to O8E Grant 8,609,816 - Korman , et al. December 17, 2 | 2013-12-17 |
| Human monoclonal antibodies to BTLA and methods of use Grant 8,580,259 - Korman , et al. November 12, 2 | 2013-11-12 |
| Monoclonal antibodies against CD30 lacking in fucosyl residues Grant 8,491,898 - Cardarelli , et al. July 23, 2 | 2013-07-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 